Moderator
Sheng-Ying (Luke) Ko (Taiwan)
Vice President,Medical and Clinical Affairs of Medigen Vaccine Biologics Corp. (MVC)
Short Biography
Job Title: | Vice President |
Position: | Medical and Clinical Affairs |
Institution: | Medigen Vaccine Biologics Corp. (MVC) |
Major Field: | Clinical Development, Medical Affairs |
Education: | M.D. – National Taiwan University (Tiawan) Master of Law – National Chengchi University (Taiwan) |
Professional Experience: | Asia Area Medical Director, AstraZeneca APMA Regional Medical Director, Dermatology and Immunology, Novartis Chief Scientific Officer, Novartis Taiwan |
Dr. Luke Ko is an experienced leader in clinical development and medical affairs, with over 17 years of experience in the pharmaceutical and biotechnology industry, alongside 6 years of clinical practice. Currently serving as Vice President of Medical and Clinical Affairs at Medigen Vaccine Biologics Corp. (MVC), Luke plays a key role in driving the company’s medical strategy and clinical development programs.
Before joining MVC, Luke held several leadership roles in multinational pharmaceutical companies, including Asia Area Medical Director at AstraZeneca, Regional Medical Director for Dermatology and Immunology at Novartis, and Country Medical Director for Novartis Taiwan.
Luke holds a Doctor of Medicine degree from National Taiwan University and is a trained psychiatrist. In addition, he earned a Master of Laws (LL.M.) degree from National Chengchi University in Taiwan. With extensive experience across the Asia-Pacific region, Luke is passionate about advancing innovative therapies and improving patient access to cutting-edge medical solutions.